Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

(ANTX) (ANTX) Stock Forecast & Price Target

Get the Latest News and Ratings for ANTX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for (ANTX) and its competitors.

Sign Up

ANTX Analyst Ratings Over Time

TypeCurrent Forecast
10/7/23 to 10/6/24
1 Month Ago
9/7/23 to 9/6/24
3 Months Ago
7/9/23 to 7/8/24
1 Year Ago
10/7/22 to 10/7/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$2.00$2.00$4.33$24.50
Forecasted Upside86.92% Upside96.08% Upside73.33% Upside64.32% Upside
Consensus Rating
Hold
Hold
Moderate Buy
Buy

ANTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ANTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

(ANTX) Stock vs. The Competition

Type(ANTX)Medical CompaniesS&P 500
Consensus Rating Score
2.00
2.79
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside86.92% Upside10,592.03% Upside7.04% Upside
News Sentiment Rating
Neutral News

See Recent ANTX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/9/2024Leerink Partnrs
0 of 5 stars
J. Schwartz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
8/9/2024Evercore ISI
2 of 5 stars
L. Bayko
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeIn-Line ➝ Underperform
8/9/2024JMP Securities
2 of 5 stars
 Lower TargetMarket Outperform ➝ Market Outperform$6.00 ➝ $3.00+13.64%
8/9/2024Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$5.00 ➝ $1.00-62.12%
4/1/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 04:28 AM ET.


ANTX Forecast - Frequently Asked Questions

According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for (ANTX) is $2.00, with a high forecast of $3.00 and a low forecast of $1.00.

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for (ANTX) in the last year. There is currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ANTX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ANTX, but not buy additional shares or sell existing shares.

According to analysts, (ANTX)'s stock has a predicted upside of 86.92% based on their 12-month stock forecasts.

Over the previous 90 days, (ANTX)'s stock had 3 downgrades by analysts.

(ANTX) has been rated by research analysts at Evercore ISI, JMP Securities, Leerink Partners, and Leerink Partnrs in the past 90 days.

Analysts like (ANTX) less than other "medical" companies. The consensus rating for (ANTX) is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ANTX compares to other companies.


This page (NYSE:ANTX) was last updated on 10/6/2024 by MarketBeat.com Staff
From Our Partners